These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 77855)

  • 21. Effects of pancreozymin and secretin on insulin release and the role of the exocrine pancreas.
    Danielsson A; Lernmark A
    Diabetologia; 1974 Oct; 10(5):407-9. PubMed ID: 4615962
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathology of external and internal secretion of the pancreas in patients with chronic pancreatitis (studies with secretin and pancreozymin].
    Geller LI; Kazimirchik AP; Romanets VA; Bulgakova OS
    Klin Med (Mosk); 1974 Jul; 52(7):40-5. PubMed ID: 4603730
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoimmunity and the endocrine pancreas.
    Doniach D; Bottazzo GF
    Pathobiol Annu; 1977; 7():327-46. PubMed ID: 339152
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Distribution of radioimmunoassayable gastrin, secretin, pancreozymin and enteroglucagon in rat, dog, and baboon gut.
    Bloom SR; Bryant MG
    J Endocrinol; 1973 Nov; 59(2):xliv. PubMed ID: 4202428
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. II. Insulin responses to secretin and pancreozymin in experimentally-induced pancreatic exocrine insufficiency.
    Goberna R; Fussgänger RD; Raptis S; Telib M; Pfeiffer EF
    Diabetologia; 1971 Apr; 7(2):68-72. PubMed ID: 4932010
    [No Abstract]   [Full Text] [Related]  

  • 26. Secretion of glucagon from the isolated, perfused canine pancreas.
    Iversen J
    J Clin Invest; 1971 Oct; 50(10):2123-36. PubMed ID: 5116204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Truncular vagotomy and its effect on upper abdominal organs with special reference to the endocrine pancreas. Clinical and experimental observations].
    Reding R
    Zentralbl Chir; 1974 Jun; 99(24):737-47. PubMed ID: 4603941
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of gastrointestinal polypeptides on hormone content of endocrine pancreas in the rat.
    Yamada T; Solomon TE; Petersen H; Levin SR; Lewin K; Walsh JH; Grossman MI
    Am J Physiol; 1980 Jun; 238(6):G526-30. PubMed ID: 6104442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of four cell types in the human endocrine pancreas by immunoelectron microscopy.
    Pelletier G
    Diabetes; 1977 Aug; 26(8):749-56. PubMed ID: 328332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus.
    Frier BM; Faber OK; Binder C; Elliot HL
    Diabetologia; 1978 May; 14(5):301-4. PubMed ID: 348540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal hormones and insulin release: in vitro studies using rabbit pancreas.
    Turner DS
    Horm Metab Res; 1969 Jul; 1(4):168-74. PubMed ID: 4946720
    [No Abstract]   [Full Text] [Related]  

  • 32. Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides.
    Robberecht P; Deschodt-Lanckman M; Woussen-Colle MC; De Neef P; Camus JC; Christophe J
    Mol Pharmacol; 1980 Mar; 17(2):268-74. PubMed ID: 6156397
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Oka T; Tani S; Baba S
    Dig Dis Sci; 1987 Oct; 32(10):1136-44. PubMed ID: 2443324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal control of pancreatic endocrine and exocrine secretion.
    Youngs G
    Gut; 1972 Feb; 13(2):154-61. PubMed ID: 4558161
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure antigenicity relationships of glucagon and related peptides.
    Vinik AI; Hardcastle A
    Horm Metab Res; 1974 Sep; 6(5):396-9. PubMed ID: 4138193
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.
    Ipp E; Dobbs RE; Harris V; Arimura A; Vale W; Unger RH
    J Clin Invest; 1977 Nov; 60(5):1216-9. PubMed ID: 908761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of cholecystokinin-pancreozymin (CCK) in human plasma and tissue by a specific radioimmunoassay and the immunohistochemical identification of pancreozymin-producing cells in the duodenum of humans.
    Schlegel W; Raptis S; Grube D; Pfeiffer EF
    Clin Chim Acta; 1977 Oct; 80(2):305-16. PubMed ID: 562241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of TRF immunoreactivity in marginal islet cells in rat pancreas.
    Koivusalo F; Leppäluoto J; Knip M; Rajaniemi H
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):398-404. PubMed ID: 7020318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations for immune histochemical evidence in insulin, glucagon, and gastrin in isolated islets of Langerhans of the rat and mouse (author's transl)].
    Dorn A; Lorenz D; Hahn HJ; Koch G; Ziegler M
    Acta Histochem; 1974; 49(1):153-7. PubMed ID: 4211112
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific biologic effects of intestinal glucagon-like materials.
    Gutman RA; Fink G; Voyles N; Selawry H; Penhos JC; Lepp A; Recant L
    J Clin Invest; 1973 May; 52(5):1165-75. PubMed ID: 4349485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.